Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 14, 2008; 14(18): 2797-2801
Published online May 14, 2008. doi: 10.3748/wjg.14.2797
Published online May 14, 2008. doi: 10.3748/wjg.14.2797
Figure 1 Mechanism of action of UFT.
Figure 2 Biochemical modulation of UFT.
Figure 3 Cumulative survival rates in patients with stage IVA HCC who received UFT-E and those who did not.
Figure 4 Cumulative survival rates in patients with stage IVA hepatocellular carcinoma according to response to treatment.
CR: Complete response; PR: Partial response; NC: No change; PD: Progressive disease.
Figure 5 Cumulative survival rates in patients with tumor occlusion of the portal vein who received modified EEP therapy.
- Citation: Ishikawa T. Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma. World J Gastroenterol 2008; 14(18): 2797-2801
- URL: https://www.wjgnet.com/1007-9327/full/v14/i18/2797.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2797